The KRT5 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population featuring targeted disruption of the KRT5 gene. Unlike clonal isolates, this heterogeneous pool preserves the complexity of gene editing outcomes, providing a robust loss-of-function model for studying keratin 5 biology while minimizing clonal variability. The product is provided as a ready-to-use vial of viable cells for immediate culture and downstream experimentation.
The host cell line, HeLa, is a classic human cervical epithelial adenocarcinoma model that harbors integrated HPV18 sequences and has been instrumental in biomedical research for decades. These cells retain fundamental programs of epithelial differentiation and cytoskeletal organization, making them an ideal platform to investigate intermediate filament dynamics and mechanical integrity in a cancer-relevant context.
KRT5 encodes keratin 5, a type II intermediate filament protein that is a core structural component of the cytoskeleton in basal epithelial cells. KRT5 forms obligate heterodimers with keratin 14 (KRT14), which then assemble into a dense, mechanically resilient network that confers tensile strength and maintains epithelial tissue architecture. The expression of KRT5 is under the control of the master epithelial transcription factor p63 and AP-1 transcription factors, acting downstream of growth factor signaling pathways. These keratin filaments are anchored to cell?Ccell and cell?Cmatrix junctions through interactions with desmosomal and hemidesmosomal linker proteins, including desmoplakin, plakoglobin, and plectin. By connecting intermediate filaments to adhesion complexes, KRT5 plays a critical role in maintaining epithelial sheet integrity and coordinating cellular responses to mechanical stress. Disruption of KRT5 function abrogates filament formation, leading to compromised mechanical stability, altered cell adhesion, and enhanced migratory behavior. Downstream consequences include the destabilization of KRT14, impaired desmosome assembly, and potential activation of epithelial?Cmesenchymal transition and stress-sensitive signaling pathways.
In the HeLa cellular context, KRT5 knockout provides a physiologically relevant model system for dissecting how keratin intermediate filaments influence transformed epithelial cell behavior. This model recapitulates key features of skin fragility disorders, such as epidermolysis bullosa simplex, and aids in understanding the role of cytoskeletal reorganization in epithelial cancer progression, including migration and invasion. The polyclonal nature ensures broad representation of editing events, facilitating robust phenotypic screening.
This polyclonal KRT5 knockout population is ideally suited for a wide array of experimental applications. Loss of KRT5 protein can be confirmed by western blotting, while immunofluorescence microscopy reveals the consequent collapse of the keratin network and mislocalization of associated proteins such as KRT14. Functional assays??including wound healing, transwell migration, and invasion assays??permit quantitative analysis of altered cell motility. Mechanical stress assays, such as cell stretch or atomic force microscopy, directly probe epithelial fragility. Co-immunoprecipitation with KRT14 enables assessment of heterodimer disruption, and apoptosis assays measure heightened sensitivity to mechanical or chemical insults. Overall, these cells serve as a versatile platform for studying epithelial cell mechanics, modeling keratin-related diseases, and screening for modulators of intermediate filament function. For additional technical information, please contact Ascent Research.
